🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

North Korea steps up coronavirus prevention after first possible infection

Published 2020-07-28, 03:32 a/m

By Sangmi Cha

SEOUL (Reuters) - North Korea introduced tougher prevention measures against the novel coronavirus on Tuesday, state media reported, after it locked down the border town of Kaesong to tackle what could be its first publicly confirmed case of the respiratory disease.

Strict quarantine measures and the screening of districts were in progress, and test kits, protective clothing, and medical equipment were being rapidly supplied, the North's KCNA state news agency said.

The measures come after North Korean leader Kim Jong Un declared an emergency on Sunday after a person suspected of being infected with the virus returned from South Korea.

North Korea had reported testing 1,211 people for the virus as of July 16 with all returning negative results, the World Health Organization (WHO) said in a statement sent to Reuters on Monday. The report said 696 nationals were under quarantine.

Primers and probes for machines capable of facilitating 1,000 tests have arrived in North Korea, WHO said. There are 15 laboratories designated to test COVID-19 in the country.

North Korea has a limited healthcare system with hospitals that lack adequate electricity, medicine, and water. It has long depended on the WHO to procure drugs as sanctions against the country made imports difficult.

In the past months, it received test kits and protective gear from the WHO and countries including Russia, but some of these were held up at the border because of the country's own restrictions.

North Korea said earlier this month it has started early clinical trial on a vaccine for the virus, but experts are sceptical.

The country lacks the technology or laboratories to develop COVID-19 vaccines, said Choi Jung-hun, a former North Korean doctor who defected to the South in 2012.

"North Korea wasn't even capable of testing people just until three or four months ago," said Choi, now a researcher at Korea University. "It is groundless for them to claim they are enrolling participants for human trials of COVID-19 vaccines."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.